1. Pegaptanib for neovascular age-related macular degeneration;Gragoudas;N Engl J Med,2004
2. Phase III study shows Lucentis improved vision in patients with wet age-related macular degeneration[press release],2005
3. Preliminary phase III data from head-to-head study of Lucentis shows Lucentis improved vision compared to Visudyne in patients with wet age-related macular degeneration [press release],2006
4. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration: 2-year results of the MARINA study. N Engl J Med. In press.
5. Ranibizumab for treatment of neovascular age-related macular degeneration;Heier;Ophthalmology,2006